Dr. Lal PathLabs LimitedNSE: LALPATHLAB

Press Release May 10 2024

· Issued by Dr. Lal PathLabs Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The company reported a revenue increase in the fourth quarter compared to the same period last year, along with significant growth in EBITDA and profit after tax. The press release highlights the company's strong performance in the diagnostic and healthcare services sector.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated May 10, 2024, titled "Press Release on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024".

Dr. Lal PathLabs Limited on 6ix

Earlier from Dr. Lal PathLabs

Later from Dr. Lal PathLabs

All Dr. Lal PathLabs news releases